Literature DB >> 14587869

Mdm2: A regulator of cell growth and death.

Dania Alarcon Vargas1, Shoichi Takahashi, Ze'ev Ronai.   

Abstract

The interplay between Mdm2 and p53 represents one of the better-known paradigms of the relationship between an oncogene and a tumor suppressor gene. The Mdm2 protein is a key regulator of cell growth and death and plays a pivotal role in the transformation of normal cells into tumor cells, the hallmark of an oncogene. The primary role of Mdm2 under nonstressed conditions is to target the degradation ofthe tumor suppressor protein p53. In response to stress, however, p53 is not affected by Mdm2 and functions as a transcription factor that induces the transcription of Mdm2 as well as of genes involved in growth control or apoptosis. The effect of Mdm2 on the regulation of cell growth and death depends on p53 but also on a growing number of p53-independent targets. This overview summarizes our current understanding of Mdm2 and p53 regulation, function, and interaction in normal and tumor states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587869     DOI: 10.1016/s0065-230x(03)01001-7

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  13 in total

Review 1.  Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  beta-Peptides as inhibitors of protein-protein interactions.

Authors:  Joshua A Kritzer; Olen M Stephens; Danielle A Guarracino; Samuel K Reznik; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2005-01-03       Impact factor: 3.641

3.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Vladimir N Uversky; Zoran Obradovic
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

4.  ROS and p53 in regulation of UVB-induced HDM2 alternative splicing.

Authors:  Lingying Tong; Shiyong Wu
Journal:  Photochem Photobiol       Date:  2014-07-26       Impact factor: 3.421

5.  MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.

Authors:  Jer-Yen Yang; Cong S Zong; Weiya Xia; Yongkun Wei; Mohamed Ali-Seyed; Zheng Li; Kristine Broglio; Donald A Berry; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

6.  Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.

Authors:  Yanning Rui; Zhen Xu; Shuyong Lin; Qinxi Li; Hongliang Rui; Wen Luo; Hai-Meng Zhou; Po-Yan Cheung; Zhenguo Wu; Zhiyun Ye; Peng Li; Jiahuai Han; Sheng-Cai Lin
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

7.  Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH.

Authors:  Hatem Q Al-Maghraby; Walid E Khalbuss; Uma N M Rao; Kathleen Cieply; Sanja Dacic; Sara E Monaco
Journal:  Cytojournal       Date:  2010-04-06       Impact factor: 2.091

8.  Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Ming-Hai Wang; Horrick Sharma; Shivaputra Patil; Jianwei Zhou; Hui Wang; Debabrata Mukhopadhyay; John K Buolamwini; Ruiwen Zhang
Journal:  Gastroenterology       Date:  2014-07-10       Impact factor: 22.682

9.  Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.

Authors:  Nathalie Mouraret; Elisabeth Marcos; Shariq Abid; Guillaume Gary-Bobo; Mirna Saker; Amal Houssaini; Jean-Luc Dubois-Rande; Laurent Boyer; Jorge Boczkowski; Geneviève Derumeaux; Valérie Amsellem; Serge Adnot
Journal:  Circulation       Date:  2013-03-19       Impact factor: 29.690

10.  Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.

Authors:  Rayan S Moussa; Zaklina Kovacevic; Des R Richardson
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.